KINIKSA PHARMACEUTICALS-A (KNSA)

BMG5269C1010 - Common Stock

18.72  +0.17 (+0.92%)

After market: 18.72 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
38.5M220.2M
471.95%		270.259M
22.73%		390.59M
44.52%
EBITDA
YoY % growth
-154.24M
0.48%		12.2M
107.91%		-22.855M
-287.34%		-26.125M
-14.31%		N/AN/AN/A
EBIT
YoY % growth
-156.6M
0.51%		9.8M
106.26%		-25.196M
-357.10%		-17.233M
31.60%		N/AN/A
Operating Margin
-406.75%4.45%-9.32%-4.41%N/AN/A
EPS
YoY % growth
-2.30
10.85%		2.59
212.61%		0.18
-93.05%		-0.17
-193.50%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.11
-151.81%
Revenue
Q2Q % growth		90.459M
26.57%
EBITDA
Q2Q % growth		-6.12MN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.222M
-161.01%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.25
-38.89%		-0.17-0.08-50.06%
Q4 2023
Q2Q % growth		 0.35
483.33%		-0.140.49345.10%
Q3 2023
Q2Q % growth		 -0.20
-106.29%		-0.17-0.03-17.06%
Q2 2023
Q2Q % growth		 0.21
172.41%		-0.170.38222.91%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 79.858M
65.17%		80.029M-171K-0.21%
Q4 2023
Q2Q % growth		 83.395M
34.77%		73.459M9.936M13.53%
Q3 2023
Q2Q % growth		 67.05M
-32.37%		65.736M1.314M2.00%
Q2 2023
Q2Q % growth		 71.47M
165.00%		53.24M18.23M34.24%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 3.92% 51.18% 71.3%
Revenue0% -1.14% 0.05% 8.95%